Approvals of New Prescription Drugs at Risk in Shutdown – WSJ

http://bit.ly/2U09BHG

200) && (this.width >= this.height) ? 200: true); max-height: 200px; height: expression((this.height > 200) && (this.height >= this.width) ? 200: true); border: none;’/>
The FDA is set to run out of money early next month to evaluate new prescription drugs if the government shutdown continues, potentially slowing the release of new prescription therapies.

posted by friends:
 (2)
@WSJRisk on Twitter
@WSJRisk: The FDA is set to run out of money early next month to evaluate new prescription drugs if the government shutdown continues, potentially slowing the release of new therapies including cancer treatments.
on.wsj.com/2FHPU3i

@WSJ on Twitter
@WSJ: The FDA is set to run out of money early next month to evaluate new prescription drugs if the government shutdown continues on.wsj.com/2Dm5EHF

@WSJRisk on Twitter
@WSJRisk: Federal government shutdown threatens to dry up approvals of new prescription drugs on.wsj.com/2DkvYC0

posted by followers of the list:
 (0)

Vía All News on ‘The Twitter Times: v/2019’ https://on.wsj.com/2FLH4l5

Leave a comment